Ending tuberculosis in China: health system challenges

Lancet Public Health. 2021 Dec;6(12):e948-e953. doi: 10.1016/S2468-2667(21)00203-6.

Abstract

China has made remarkable progress in reducing tuberculosis cases and deaths during the past three decades; however, it is still far from achieving the targets set out in the WHO End TB Strategy. Since the 2000s, China has tried to transform its vertical tuberculosis control programme led by the Chinese Center for Disease Control and Prevention (CDC) into an integrated system under the collaboration of CDC, tuberculosis-designated hospitals, and primary health centres. Such a transition has faced many challenges. Profit-driven practices in hospitals designated to tuberculosis and an absence of adequate tuberculosis-related training for health professionals are partially jeopardising the quality of tuberculosis care. In addition, primary health-care providers are not incentivised to make referrals and manage cases effectively. The CDC does not have the administrative power to influence hospital practices or deploy resources to support community-based tuberculosis control activities. Furthermore, an absence of policy coherence and effective coordination causes challenges for quality tuberculosis care that is affordable and accessible. Improving policy dialogues and multi-level coordination within the government is fundamental to successfully ending tuberculosis in China and other countries facing similar challenges.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • China / epidemiology
  • Delivery of Health Care / economics
  • Delivery of Health Care / organization & administration*
  • Delivery of Health Care / standards*
  • Forecasting
  • Goals
  • Health Policy*
  • Humans
  • National Health Programs / economics
  • National Health Programs / organization & administration*
  • National Health Programs / standards*
  • Tuberculosis / prevention & control*